Reporting antimicrobial susceptibilities and phenotypes of resistance to vancomycin in vancomycin-resistant Enterococcus spp. clinical isolates: A nationwide proficiency study

Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jun-Jul;41(6):335-341. doi: 10.1016/j.eimce.2021.11.013. Epub 2023 Jan 5.

Abstract

Introduction: The ability of Spanish microbiology laboratories to (a) determine antimicrobial susceptibility (AS), and (b) correctly detect the vancomycin resistance (VR) phenotype in vancomycin-resistant Enterococcus spp. (VRE) was evaluated.

Methods: Three VRE isolates representing the VanA (E. faecium), VanB (E. faecium) and VanC (E. gallinarum) VR phenotypes were sent to 52 laboratories, which were asked for: (a) AS method used; (b) MICs of ampicillin, imipenem, vancomycin, teicoplanin, linezolid, daptomycin, ciprofloxacin, levofloxacin and quinupristin-dalfopristin, and high-level resistance to gentamicin and streptomycin; (c) VR phenotype.

Results: (a) The most frequently used system was MicroScan; (b) according to the system, the highest percentage of discrepant MICs was found with gradient strips (21.3%). By antimicrobial, the highest rates of discrepant MICs ranged 16.7% (imipenem) to 0.7% (linezolid). No discrepant MICs were obtained with daptomycin or levofloxacin. Mayor errors (MEs) occurred with linezolid (1.1%/EUCAST) and ciprofloxacin (5.0%/CLSI), and very major errors (VMEs) with vancomycin (27.1%/EUCAST and 33.3%/CLSI) and teicoplanin (5.7%/EUCAST and 2.3%/CLSI). For linezolid, ciprofloxacin, and vancomycin, discrepant MICs were responsible for these errors, while for teicoplanin, errors were due to a misassignment of the clinical category. An unacceptable high percentage of VMEs was obtained using gradient strips (14.8%), especially with vancomycin, teicoplanin and daptomycin; (c) 86.4% of the centers identified VanA and VanB phenotypes correctly, and 95.0% the VanC phenotype.

Conclusion: Most Spanish microbiology laboratories can reliably determine AS in VRE, but there is a significant percentage of inadequate interpretations (warning of false susceptibility) for teicoplanin in isolates with the VanB phenotype.

Keywords: Antimicrobial susceptibility; Control de calidad; Enterococcus spp.; Estudio multicéntrico nacional; National multicenter study; Quality control; Resistencia a vancomicina; Sensibilidad Antimicrobiana; Vancomycin resistance.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Ciprofloxacin
  • Daptomycin* / pharmacology
  • Imipenem
  • Levofloxacin
  • Linezolid / pharmacology
  • Phenotype
  • Teicoplanin / pharmacology
  • Vancomycin / pharmacology
  • Vancomycin-Resistant Enterococci* / genetics

Substances

  • Vancomycin
  • Anti-Bacterial Agents
  • Teicoplanin
  • Daptomycin
  • Linezolid
  • Levofloxacin
  • Ciprofloxacin
  • Imipenem